ITC replaces TCS as India's most admired company

In comparison, the list for 2013 was topped by TCS, followed by HUL, ITC, Infosys and SBI at in the top-five

Press Trust of India New Delhi
Last Updated : Aug 24 2014 | 1:12 PM IST
Tobacco-to-FMCG conglomerate ITC has replaced Tata group's IT giant TCS as the country's most admired company on a Fortune magazine list, which has got as many as 19 new entrants including Cognizant, Birla group firm Idea Cellular and discom BSES Rajdhani Power Ltd.

In the latest list for the year 2014, ITC is followed by engineering and infrastructure major Larsen and Toubro (L&T), another FMCG giant Hindustan Unilever, carmaker Maruti Suzuki and public sector bank SBI among the top five most admired companies in India.

In comparison, the list for 2013 was topped by TCS, followed by HUL, ITC, Infosys and SBI at in the top-five. TCS has moved down to the sixth position this year.

Releasing the third annual list of 45 most admired companies in India for the year 2014, the business magazine said there are as many as 19 new entities on the list including GMR Infra, Shapoorji Pallonji, Idea Cellular, BSES Rajdhani Power Ltd (BRPL), Cognizant and Abbott Pharma.

The list has been prepared in in collaboration with the Hay Group.

In sectoral rankings, NTPC is at the top position for the power sector and is followed by Tata Power, BRPL, PowerGrid and BSES Yamuna Power in the top five. These are followed by NPCIL, Adani Power, NHPC, CESC, Gujarat State Electricity, Suzlon Power, Kalpataru Power Transmission and Gujarat Urja Vikas Nigam.

Out of these, three companies have found place on the main list -- NTPC at 22nd, Tata Power at 27th, BRPL at 35th position.

For the telecom sector, Vodafone India is on the top and is followed by Bharti Airtel, Idea Cellular, Tata Communications, Reliance Communications, Aircel, Tata Tele, MTNL, BSNL, MTS, Tulip Telecom and Uninor.

The list for pharma and healthcare sector is topped by Apollo Hospitals, followed by Abbott India, GSK Pharma, Cadila, Sun Pharma, Cipla and Ranbaxy, among others.

The rankings are based on a survey of over 1,500 companies as per responses from the top industry executives, including on the basis of peer group response.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 24 2014 | 12:55 PM IST

Next Story